FUNCTIONAL COMPARISON OF THE BASIC DOMAINS OF THE TAT PROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 IN TRANS ACTIVATION

被引:28
|
作者
ELANGOVAN, B [1 ]
SUBRAMANIAN, T [1 ]
CHINNADURAI, G [1 ]
机构
[1] ST LOUIS UNIV,SCH MED,INST MOLEC VIROL,3681 PK AVE,ST LOUIS,MO 63110
关键词
D O I
10.1128/JVI.66.4.2031-2036.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The trans-activator Tat proteins coded by human immunodeficiency virus type 1 (HIV-1) and HIV-2 appear to be similar in structure and function. However, the Tat protein of HIV-2 (Tat2) activates the HIV-1 long terminal repeat (LTR) less efficiently than Tat1 (M. Emerman, M. Guyader, L. Montagnier, D. Baltimore, and M. A. Muesing, EMBO J. 6:3755-3760, 1987). To determine the functional domain of Tat2 which contributes to this incomplete reciprocity, we have carried out domain substitution between Tat1 and Tat2 by exchanging the basic domains involved in Tat interaction with its target trans-activation-response (TAR) RNA structure. Our results indicate that Tat1 proteins containing substitutions of either 8 or 14 amino acids of the basic domain of Tat2 exhibited reduced trans activation of the HIV-1 LTR by about 1/20 or one-fourth the level induced by wt Tat1. In contrast, Tat2 containing a substitution of the 9-amino-acid basic domain of Tat1 trans activated HIV-1 LTR like native Tat1. A substitution of the highly conserved core domain of Tat2 with that of Tat1 did not have any significant effect on trans activation of the HIV-1 LTR. These results indicate that the basic domain of Tat2 contributes to its inefficient trans activation of the HIV-1 LTR. Mutation of an acidic residue (Glu) located between the core domain and the Arg-rich basic domain of Tat2 at position 77 to a Gly residue increased the activity of Tat2 substantially. These results further suggest that the presence of an acidic residue (Glu) adjacent to Arg-rich sequences may at least partially contribute to the reduced activity of the Tat2 basic domain.
引用
收藏
页码:2031 / 2036
页数:6
相关论文
共 50 条
  • [31] THE EFFECTS OF CYSTEINE MUTATIONS ON THE REVERSE TRANSCRIPTASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    HIZI, A
    SHAHARABANY, M
    TAL, R
    HUGHES, SH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (02) : 1293 - 1297
  • [32] COMPARATIVE-ANALYSIS OF REV FUNCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    GARRETT, ED
    CULLEN, BR
    JOURNAL OF VIROLOGY, 1992, 66 (07) : 4288 - 4294
  • [33] EVALUATION OF RAPID TEST FOR DETECTION OF ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    ASIHENE, PJ
    KLINE, RL
    MOSS, MW
    CARELLA, AV
    QUINN, TC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) : 1341 - 1342
  • [34] EVIDENCE FOR NEUROTOXIC ACTIVITY OF TAT FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SABATIER, JM
    VIVES, E
    MABROUK, K
    BENJOUAD, A
    ROCHAT, H
    DUVAL, A
    HUE, B
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 961 - 967
  • [35] LOCALIZATION OF IMMUNOGENIC DOMAINS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE
    HUANG, ML
    ESSEX, M
    LEE, TH
    JOURNAL OF VIROLOGY, 1991, 65 (09) : 5073 - 5079
  • [36] CHANGES IN CELLULAR PROTEINS ASSOCIATED WITH THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATOR PROTEIN TAT
    RANGANATHAN, PN
    RANGANATHAN, S
    SRINIVASAN, A
    DNA AND CELL BIOLOGY, 1993, 12 (09) : 831 - 837
  • [37] COMPARISON OF INDIRECT IMMUNOFLUORESCENCE AND MEMBRANE FLUORESCENCE ASSAYS FOR THE DIFFERENTIATION OF ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    GALLO, D
    HOFFMAN, MN
    YEH, ET
    GEORGE, JR
    HANSON, CV
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) : 2275 - 2278
  • [38] EFFECTS OF THE TAT BASIC DOMAIN ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATION, USING CHEMICALLY SYNTHESIZED TAT PROTEIN AND TAT PEPTIDES
    VIVES, E
    CHARNEAU, P
    VANRIETSCHOTEN, J
    ROCHAT, H
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 3343 - 3353
  • [39] IDENTIFICATION OF LENTIVIRUS TAT FUNCTIONAL DOMAINS THROUGH GENERATION OF EQUINE INFECTIOUS-ANEMIA VIRUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT GENE CHIMERAS
    CARROLL, R
    MARTARANO, L
    DERSE, D
    JOURNAL OF VIROLOGY, 1991, 65 (07) : 3460 - 3467
  • [40] TRANSCRIPTIONAL ACTIVATION OF THE TAT-DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUS - EFFECT OF INTERFERON
    POPIK, W
    PITHA, PM
    VIROLOGY, 1992, 189 (02) : 435 - 447